Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Ligand Pharmaceuticals Incorporated, 3 years.
Ligand Pharmaceuticals Incorporated
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 14, 2024 | Ligand Pharmaceuticals Incorporated | Grant or award | +1,252 | — | — |
| Apr 24, 2024 | Ligand Pharmaceuticals Incorporated | Option exercise | +2,893 | $39.35 | $113,840 |
| Jun 9, 2023 | Ligand Pharmaceuticals Incorporated | Grant or award | +1,142 | — | — |
| May 16, 2023 | Ligand Pharmaceuticals Incorporated | Open-market sale | −4,444 | $77.20 | $343,077 |
| May 8, 2023 | Ligand Pharmaceuticals Incorporated | Option exercise | +6,408 | $18.82 | $120,599 |
| May 8, 2023 | Ligand Pharmaceuticals Incorporated | Open-market sale | −5,819 | $76.51 | $445,212 |
| May 8, 2023 | Ligand Pharmaceuticals Incorporated | Open-market sale | −589 | $77.10 | $45,412 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.